These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26563437)

  • 1. Papillary thyroid cancer in a patient with congenital goitrous hypothyroidism due to a novel deletion in NIS gene.
    Agretti P; Bagattini B; De Marco G; Di Cosmo C; Dionigi G; Vitti P; Tonacchera M
    Endocrine; 2016 Oct; 54(1):256-258. PubMed ID: 26563437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Papillary carcinoma arising from dyshormonogenetic goiter].
    Kallel R; Mnif Hachicha L; Mnif M; Hammami B; Ayadi L; Bahri I; Ghorbel A; Abid M; Makni S; Boudawara T
    Ann Endocrinol (Paris); 2009 Dec; 70(6):485-8. PubMed ID: 19880092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary carcinoma of the thyroid developed in congenital dyshormonogenetic hypothyroidism without goiter: Diagnosis by FNAB.
    Drut R; Moreno A
    Diagn Cytopathol; 2009 Oct; 37(10):707-9. PubMed ID: 19670221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic analysis of dyshormonogenetic goiter.
    Bhalekar S; Shetty D; Mhatre D; Bhalekar H
    Diagn Cytopathol; 2021 Nov; 49(11):E415-E418. PubMed ID: 34288592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPO gene mutations associated with thyroid carcinoma: Case report and literature review.
    Zhu H; Peng YG; Ma SG; Liu H
    Cancer Biomark; 2015; 15(6):909-13. PubMed ID: 26406404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of thyroid disorders.
    Gubbay N
    Ear Nose Throat J; 1985 Jul; 64(7):337-50. PubMed ID: 3841801
    [No Abstract]   [Full Text] [Related]  

  • 7. First case of fetal goitrous hypothyroidism due to SLC5A5/NIS mutations.
    Stoupa A; Al Hage Chehade G; Kariyawasam D; Tohier C; Bole-Feysot C; Nitschke P; Thibault H; Jullie ML; Polak M; Carré A
    Eur J Endocrinol; 2020 Nov; 183(5):K1-K5. PubMed ID: 32805706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital goitrous primary hypothyroidism in two German families caused by novel thyroid peroxidase (TPO) gene mutations.
    Altmann K; Hermanns P; Mühlenberg R; Fricke-Otto S; Wentzell R; Pohlenz J
    Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):343-6. PubMed ID: 23512414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital hypothyroidism and late-onset goiter: identification and characterization of a novel mutation in the sodium/iodide symporter of the proband and family members.
    Montanelli L; Agretti P; Marco Gd; Bagattini B; Ceccarelli C; Brozzi F; Lettiero T; Cerbone M; Vitti P; Salerno M; Pinchera A; Tonacchera M
    Thyroid; 2009 Dec; 19(12):1419-25. PubMed ID: 19916865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reparative change with extensive squamous metaplasia: a potential diagnostic pitfall on thyroid aspiration.
    Leung AH; Kort KC; Khurana KK
    South Med J; 2010 Mar; 103(3):268-71. PubMed ID: 20134379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Missense Mutation in the SLC5A5 Gene in a Sudanese Family with Congenital Hypothyroidism.
    Watanabe Y; Ebrhim RS; Abdullah MA; Weiss RE
    Thyroid; 2018 Aug; 28(8):1068-1070. PubMed ID: 29759035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital dyshormonogenic hypothyroidism with goiter caused by a sodium/iodide symporter (SLC5A5) mutation in a family of Shih-Tzu dogs.
    Soler Arias EA; Castillo VA; Garcia JD; Fyfe JC
    Domest Anim Endocrinol; 2018 Oct; 65():1-8. PubMed ID: 29777899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinoma.
    Raef H; Al-Rijjal R; Al-Shehri S; Zou M; Al-Mana H; Baitei EY; Parhar RS; Al-Mohanna FA; Shi Y
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1000-6. PubMed ID: 20089614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of genes in papillary thyroid carcinoma.
    Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms.
    Pang T; Ihre-Lundgren C; Gill A; McMullen T; Sywak M; Sidhu S; Delbridge L
    Surgery; 2010 Sep; 148(3):532-7. PubMed ID: 20236675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear nuclei are specific to papillary carcinoma in thyroid fine-needle aspirates processed by Ultrafast Papanicolaou stain.
    Yang GC
    Diagn Cytopathol; 2003 Oct; 29(4):236-7; author reply 238. PubMed ID: 14506680
    [No Abstract]   [Full Text] [Related]  

  • 20. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.